BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 9252021)

  • 1. Dopamine, as well as norepinephrine, is a link between noradrenergic nerve terminals and splenocytes.
    Bencsics A; Sershen H; Baranyi M; Hashim A; Lajtha A; Vizi ES
    Brain Res; 1997 Jul; 761(2):236-43. PubMed ID: 9252021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopamine is taken up from the circulation by, and released from, local noradrenergic varicose axon terminals in zona glomerulosa of the rat: a neurochemical and immunocytochemical study.
    Vizi ES; Tóth IE; Orsó E; Szalay KS; Szabó D; Baranyi M; Vinson GP
    J Endocrinol; 1993 Nov; 139(2):213-26. PubMed ID: 8308458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Presynaptic modulation of sympathetic neurotransmission in rat left ventricle slices: effect of pressure overload.
    Akers WS; Cassis LA
    J Neural Transm (Vienna); 2000; 107(8-9):885-902. PubMed ID: 11041270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of external and internal calcium on heterocarrier-mediated transmitter release.
    Fassio A; Bonanno G; Fontana G; Usai C; Marchi M; Raiteri M
    J Neurochem; 1996 Apr; 66(4):1468-74. PubMed ID: 8627300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Receptor mediated presynaptic modulation of the release of noradrenaline in human papillary muscle.
    Matkó I; Fehér E; Vizi ES
    Cardiovasc Res; 1994 May; 28(5):700-4. PubMed ID: 7912992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Local influence of endogenous norepinephrine on extracellular dopamine in rat medial prefrontal cortex.
    Gresch PJ; Sved AF; Zigmond MJ; Finlay JM
    J Neurochem; 1995 Jul; 65(1):111-6. PubMed ID: 7790854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Noradrenergic terminals are the primary source of α
    Devoto P; Flore G; Saba P; Scheggi S; Mulas G; Gambarana C; Spiga S; Gessa GL
    Prog Neuropsychopharmacol Biol Psychiatry; 2019 Mar; 90():97-103. PubMed ID: 30472147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of the release of [3H]norepinephrine from the base and body of the rat urinary bladder by endogenous adrenergic and cholinergic mechanisms.
    Somogyi GT; de Groat WC
    J Pharmacol Exp Ther; 1990 Oct; 255(1):204-10. PubMed ID: 2170623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantification and pharmacological characterization of dialysate levels of noradrenaline in the striatum of freely-moving rats: release from adrenergic terminals and modulation by alpha2-autoreceptors.
    Gobert A; Billiras R; Cistarelli L; Millan MJ
    J Neurosci Methods; 2004 Dec; 140(1-2):141-52. PubMed ID: 15589344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of [3H]dopamine release from rabbit retina.
    Dubocovich ML
    Fed Proc; 1984 Sep; 43(12):2714-8. PubMed ID: 6468669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Release of acetylcholine and noradrenaline from the cholinergic and adrenergic afferents in rat hippocampal CA1, CA3 and dentate gyrus regions.
    Milusheva E; Baranyi M; Zelles T; Mike A; Vizi ES
    Eur J Neurosci; 1994 Feb; 6(2):187-92. PubMed ID: 7909482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence that two stereochemically different alpha-2 adrenoceptors modulate norepinephrine release in rat cerebral cortex.
    Harsing LG; Vizi ES
    J Pharmacol Exp Ther; 1991 Jan; 256(1):44-9. PubMed ID: 1671099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Noradrenergic Modulation of Dopamine Transmission Evoked by Electrical Stimulation of the Locus Coeruleus in the Rat Brain.
    Park JW; Bhimani RV; Park J
    ACS Chem Neurosci; 2017 Sep; 8(9):1913-1924. PubMed ID: 28594540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of norepinephrine release by ATP-dependent K(+)-channel activators and inhibitors in guinea-pig and human isolated right atrium.
    Oe K; Sperlágh B; Sántha E; Matkó I; Nagashima H; Foldes FF; Vizi ES
    Cardiovasc Res; 1999 Jul; 43(1):125-34. PubMed ID: 10536697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in sensitivity of release modulating dopamine autoreceptors after chronic treatment with haloperidol.
    Nowak JZ; Arbilla S; Galzin AM; Langer SZ
    J Pharmacol Exp Ther; 1983 Aug; 226(2):558-64. PubMed ID: 6875865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Norepinephrine activates dopamine D4 receptors in the rat lateral habenula.
    Root DH; Hoffman AF; Good CH; Zhang S; Gigante E; Lupica CR; Morales M
    J Neurosci; 2015 Feb; 35(8):3460-9. PubMed ID: 25716845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for co-release of noradrenaline and dopamine from noradrenergic neurons in the cerebral cortex.
    Devoto P; Flore G; Pani L; Gessa GL
    Mol Psychiatry; 2001 Nov; 6(6):657-64. PubMed ID: 11673793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Halothane decreases impulse-dependent but not cytoplasmic release of dopamine from rat striatal slices.
    Adachi YU; Watanabe K; Higuchi H; Satoh T; Zsilla G
    Brain Res Bull; 2001 Dec; 56(6):521-4. PubMed ID: 11786236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurochemical interaction between dopaminergic and noradrenergic neurons in the medial prefrontal cortex.
    Pan WH; Yang SY; Lin SK
    Synapse; 2004 Jul; 53(1):44-52. PubMed ID: 15150740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulatory role of alpha adrenoceptors on the release of [3H]norepinephrine elicited by preganglionic stimulation of the cat superior cervical ganglion.
    Martínez AE; Adler-Graschinsky E
    J Pharmacol Exp Ther; 1980 Mar; 212(3):533-5. PubMed ID: 6102146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.